01-09-2006 | ORIGINAL ARTICLE
Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen
Published in: Journal of Bone and Mineral Metabolism | Issue 5/2006
Login to get access